As the consumer health company battles claims from the Trump administration that its painkiller Tylenol is linked to autism, Kenvue will bring on Halvorson as its next marketing chief.

As the consumer health company battles claims from the Trump administration that its painkiller Tylenol is linked to autism, Kenvue will bring on Halvorson as its next marketing chief.

Kimberly-Clark, manufacturer of consumer goods and personal care products, is best known for its paper-based products, ...

Kenvue (KVUE) announced that it will appoint Jonathan Halvorson to a newly created role of Chief Digital and Marketing Officer, effective November ...

The company plans to name snack food executive Jon Halvorson as it faces a crisis over concerns of links between Tylenol and autism.

Kenvue today announced that Jon Halvorson will be its new chief digital and marketing officer, effective Nov. 17. The Wall ...

Tylenol navigates how to challenge the Trump administration's claims; Netflix viewers are tired of product placement; and US ...

Kenvue (KVUE) plans to appoint Jon Halvorson as chief marketing officer amid a public relations crisis regarding claims linking Tylenol and ...

(NYSE: KVUE) today announced financial results for the third quarter ended September 28, 2025. "Throughout the third quarter, ...

Tylenol has been in the headlines for the last several weeks-though not for reasons any marketer would want. Despite a ...

NRG Therapeutics made three senior appointments in newly created roles: Sarah Almond as VP of translational biology; David Brocklebank as director of clinical operations and Kathryn Oliver as director ...

Health-care companies fell as traders rotated out of the sector. The SPDR Select Sector Health Care exchange-traded fund, which tracks the health-care industry group of the S&P 500, fell 0.6%, paring ...